Cooperative activation of Npr1 gene transcription and expression by interaction of ets-1 and p300

Hypertension

Volumn 54, Issue 1, 2009, Pages 172-178

  Kumar, Prerna ^a,b   Pandey, Kailash N ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Physiology SL 39 ^*  (United States)

Author keywords

Atrial natriuretic peptide; Gene expression; Gene transcription; Guanylyl cyclase A natriuretic peptide receptor A; Histone acetyltransferase

Indexed keywords

HISTONE ACETYLTRANSFERASE; MESSENGER RNA; NATRIURETIC PEPTIDE RECEPTOR A; PROTEIN P300; TRANSCRIPTION FACTOR ETS 1;

ANIMAL CELL; ARTICLE; BLOOD PRESSURE REGULATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; KIDNEY FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; E1A-ASSOCIATED P300 PROTEIN; HISTONE ACETYLTRANSFERASES; LUCIFERASES; MESANGIAL CELLS; MICE; MUTATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEIN C-ETS-1; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION;

EID: 67649853336     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.133033     Document Type: Article

References (48)

1. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. ife Sci. 1981;28:89-94.
2. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339:321-328.
3. Pandey KN. Emerging roles of natriuretic peptides and their receptors in pathophysiology of hypertension and cardiovascular regulation. J Am Soc Hypertens. 2008;2:210-226.
4. Drewett JG, Garbers DL. The family of guanylyl cyclase receptors and their ligands. Endocr Rev. 1994;15:135-162.
5. Pandey KN. Biology of natriuretic peptides and their receptors. Peptides. 2005;26:901-932.
6. Pandey KN, Singh S. Molecular cloning and expression of murine gua-nylate cyclase/atrial natriuretic factor receptor cdna. J Biol Chem. 1990; 265:12342-12348.
7. Oliver PM, John SW, Purdy KE, Kim R, Maeda N, Goy MF, Smithies O. Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner. Proc Natl Acad Sci U S A. 1998;95: 2547-2551.
8. Shi SJ, Vellaichamy E, Chin SY, Smithies O, Navar LG, Pandey KN. Natriuretic peptide receptor a mediates renal sodium excretory responses to blood volume expansion. Am J Physiol Renal Physiol. 2003;285: F694-F702.
9. Pandey KN, Oliver PM, Maeda N, Smithies O. Hypertension associated with decreased testosterone levels in natriuretic peptide receptor-a gene-knockout and gene-duplicated mutant mouse models. Endocrinology. 1999;140:5112-5119.
10. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, Maeda N. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor a. Proc Natl Acad Sci U S A. 1997;94:14730-14735.
11. Vellaichamy E, Khurana ML, Fink J, Pandey KN. Involvement of the nf-kappa b/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A. J Biol Chem. 2005;280:19230-19242.
12. Ellmers LJ, Scott NJ, Piuhola J, Maeda N, Smithies O, Frampton CM, Richards AM, Cameron VA. Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis. J Mol Endocrinol. 2007;38:245-257.
13. Vellaichamy E, Zhao D, Somanna N, Pandey KN. Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-a upregulates ace and at1 receptor gene expression and signaling: role in cardiac hypertrophy. Physiol Genomics. 2007;31:193-202.
14. Pitzalis MV, Sarzani R, Dessi-Fulgheri P, Iacoviello M, Forleo C, Lucarelli K, Pietrucci F, Salvi F, Sorrentino S, Romito R, Guida P, Rappelli A, Rizzon P. Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype. J Hypertens. 2003;21:1491-1496.
15. Rubattu S, Bigatti G, Evangelista A, Lanzani C, Stanzione R, Zagato L, Manunta P, Marchitti S, Venturelli V, Bianchi G, Volpe M, Stella P. Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol. 2006;48:499-505.
16. Weber M, Burian M, Dragutinovic I, Moellmann H, Nef H, Elsaesser A, Mitrovic V, Hamm C, Geisslinger G. Genetic polymorphism of the type a human natriuretic peptide receptor (NPR-A) gene contributes to the interindividual variability in the BNP system. Eur J Heart Fail. 2008;10: 482-489.
17. Chen S, Olsen K, Grigsby C, Gardner DG. Vitamin D activates type a natriuretic peptide receptor gene transcription in inner medullary collecting duct cells. Kidney Int. 2007;72:300 -306.
18. Garg R, Pandey KN. Angiotensin II-mediated negative regulation of npr1 promoter activity and gene transcription. Hypertension. 2003;41: 730-736.
19. Arise KK, Pandey KN. Inhibition and down-regulation of gene transcription and guanylyl cyclase activity of NPRA by angiotensin II involving protein kinase C. Biochem Biophys Res Commun. 2006;349: 131-135.
20. Mizui M, Isaka Y, Takabatake Y, Sato Y, Kawachi H, Shimizu F, Takahara S, Ito T, Imai E. Transcription factor Ets-1 is essential for mesangial matrix remodeling. Kidney Int. 2006;70:298-305.
21. Hultgardh-Nilsson A, Cercek B, Wang JW, Naito S, Lovdahl C, Sharifi B, Forrester JS, Fagin JA. Regulated expression of the ETS-1 transcription factor in vascular smooth muscle cells in vivo and in vitro. Circ Res. 1996;78:589-595.
22. Vo N, Goodman RH. CREB-binding protein and p300 in transcriptional regulation. J Biol Chem. 2001;276:13505-13508.
23. Blobel GA. CBP and p300: versatile coregulators with important roles in hematopoietic gene expression. J Leukoc Biol. 2002;71:545-556.
24. Jayaraman G, Srinivas R, Duggan C, Ferreira E, Swaminathan S, Soma-sundaram K, Williams J, Hauser C, Kurkinen M, Dhar R, Weitzman S, Buttice G, Thimmapaya B. P300/cAMP-responsive element-binding protein interactions with ETS-1 and ETS-2 in the transcriptional activation of the human stromelysin promoter. J Biol Chem. 1999;274: 17342-17352.
25. Segelmark M, Barrett C, Pendergraft W, Falk R, Preston G. Expression of p300-truncated fragments results in the modulation of apoptosis in rat mesangial cells. Kidney Int. 2000;57:1873-1881.
26. Kumar P, Arise KK, Pandey KN. Transcriptional regulation of guanylyl cyclase/natriuretic peptide receptor-A gene. Peptides. 2006;27: 1762-1769.
27. Pandey KN, Nguyen HT, Li M, Boyle JW. Natriuretic peptide receptor-A negatively regulates mitogen-activated protein kinase and proliferation of mesangial cells: role of cGMP-dependent protein kinase. Biochem Biophys Res Commun. 2000;271:374-379.
28. Pandey KN. Kinetic analysis of internalization, recycling and redistribution of atrial natriuretic factor-receptor complex in cultured vascular smooth-muscle cells: ligand-dependent receptor down-regulation. Biochem J. 1992;288:55-61.
29. Pandey KN, Nguyen HT, Sharma GD, Shi SJ, Kriegel AM. Ligand-regulated internalization, trafficking, and down-regulation of guanylyl cyclase/atrial natriuretic peptide receptor-A in human embryonic kidney 293 cells. J Biol Chem. 2002;277:4618-4627.
30. Cederberg A, Hulander M, Carlsson P, Enerback S. The kidney-expressed winged helix transcription factor FREAC-4 is regulated by ETS-1: a possible role in kidney development. J Biol Chem. 1999;274:165-169.
31. Gomez RA, Norwood VF. Recent advances in renal development. Curr Opin Pediatr. 1999;11:135-140.
32. Maroulakou IG, Bowe DB. Expression and function of ETS transcription factors in mammalian development: a regulatory network. Oncogene. 2000;19:6432-6442.
33. Raffetseder U, Wernert N, Ostendorf T, van Roeyen C, Rauen T, Behrens P, Floege J, Mertens PR. Mesangial cell expression of proto-oncogene ETS-1 during progression of mesangioproliferative glomerulonephritis. Kidney Int. 2004;66:622-632.
34. Yao TP, Oh SP, Fuchs M, Zhou ND, Ch'ng LE, Newsome D, Bronson RT, Li E, Livingston DM, Eckner R. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell. 1998;93:361-372.
35. Wei JQ, Shehadeh LA, Mitrani JM, Pessanha M, Slepak TI, Webster KA, Bishopric NH. Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300. Circulation. 2008;118:934 -946.
36. Suzuki H, Romano-Spica V, Papas TS, Bhat NK. ETS1 suppresses tumorigenicity of human colon cancer cells. Proc Natl Acad Sci U S A. 1995;92:4442-4446.
37. Seth A, Watson DK. Ets transcription factors and their emerging roles in human cancer. Eur J Cancer. 2005;41:2462-2478.
38. Lie-Venema H, Gittenberger-de Groot AC, van Empel LJ, Boot MJ, Kerkdijk H, de Kant E, DeRuiter MC. Ets-1 and Ets-2 transcription factors are essential for normal coronary and myocardial development in chicken embryos. Circ Res. 2003;92:749-756.
39. Lelievre E, Mattot V, Huber P, Vandenbunder B, Soncin F. Ets1 lowers capillary endothelial cell density at confluence and induces the expression of ve-cadherin. Oncogene. 2000;19:2438-2446.
40. Chan HM, La Thangue NB. P300/CBP proteins: hats for transcriptional bridges and scaffolds. J Cell Sci. 2001;114:2363-2373.
41. Czuwara-Ladykowska J, Sementchenko VI, Watson DK, Trojanowska M. Ets1 is an effector of the transforming growth factor beta (TGF-beta) signaling pathway and an antagonist of the profibrotic effects of TGF-beta. J Biol Chem. 2002;277:20399-20408.
42. Chakravarti D, Ogryzko V, Kao HY, Nash A, Chen H, Nakatani Y, Evans RM. A viral mechanism for inhibition of p300 and PCAF acetyltrans-ferase activity. Cell. 1999;96:393- 403.
43. Yanazume T, Hasegawa K, Morimoto T, Kawamura T, Wada H, Matsumori A, Kawase Y, Hirai M, Kita T. Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol Cell Biol. 2003; 23:3593-3606.
44. Kumar P, Bolden G, Arise KK, Krazit ST, Pandey KN. Regulation of natriuretic peptide receptor-A gene expression and stimulation of its guanylate cyclase activity by transcription factor Ets-1. Biosci Rep. 2009; 29:57-70.
45. Oettgen P. Regulation of vascular inflammation and remodeling by Ets factors. Circ Res. 2006;99:1159-1166.
46. Pearse DD, Tian RX, Nigro J, Iorgulescu JB, Puzis L, Jaimes EA. Angiotensin II increases the expression of the transcription factor Ets-1 in mesangial cells. Am J Physiol Renal Physiol. 2008;294:F1094-F1100.
47. Rowe SJ, Allen L, Ridger VC, Hellewell PG, Whyte MK. Caspase-1-deficient mice have delayed neutrophil apoptosis and a prolonged inflammatory response to lipopolysaccharide-induced acute lung injury. J Immunol. 2002;169:6401-6407.
48. Pei H, Li C, Adereth Y, Hsu T, Watson DK, Li R. Caspase-1 is a direct target gene of Ets1 and plays a role in Ets1-induced apoptosis. Cancer Res. 2005;65:7205-7213.